Back to companies
Xilio Therapeutics, Inc.
XLOUSNASDAQPharmaceuticals & HealthcareXilio Therapeutics, Inc.
Revenue
$43.8mn
YoY +589.9%
Operating income
-$42.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API